新型肝癌生物标志物:PI3K/AKT/mTOR通路成员与真核翻译起始因子
该研究在235例病毒相关人肝细胞癌(HCC)中免疫组化检测eIF亚基表达,并用免疫印迹比较病毒相关与非病毒相关HCC及对照。发现mTOR、pPTEN、PTEN、pAKT及多个eIF亚基在HCV相关HCC、HBV相关HCC、非病毒背景HCC、酒精性肝病和Wilson病等不同条件下显著升高。慢性乙型肝炎与丙型肝炎、HBV与HCV相关HCC及非病毒相关HCC之间表达模式存在明显差异。
要点
- mTOR和活化mTOR在慢性丙型肝炎相关HCC、无病毒背景HCC、酒精性肝病和Wilson病中显著升高。
- pPTEN、PTEN和pAKT在HBV和HCV相关HCC、慢性乙型肝炎、无病毒背景HCC、酒精性脂肪性肝炎和Wilson病中显著升高。
- p-eIF2α、eIF2α、eIF3B、eIF3D、eIF3J、p-eIF4B、eIF4G和eIF6在HCV相关HCC中上调。
核心结论
- eIFs在HCC中可能发挥作用,且与PI3K/AKT/mTOR通路相关。
- 慢性乙型肝炎与丙型肝炎、HBV与HCV相关HCC及非病毒相关HCC之间表达模式存在明显差异。
研究设计与样本
- 对235例病毒相关人HCC进行免疫组化检测eIF亚基表达。
- 采用免疫印迹分析比较病毒相关HCC、非病毒相关HCC与对照的表达。
主要发现
- mTOR和活化mTOR在慢性HCV相关HCC、无病毒背景HCC、酒精性肝病和Wilson病中显著升高。
- pPTEN、PTEN和pAKT在HBV和HCV相关HCC、慢性乙型肝炎、无病毒背景HCC、酒精性脂肪性肝炎和Wilson病中显著升高。
- p-eIF2α、eIF2α、eIF3B、eIF3D、eIF3J、p-eIF4B、eIF4G和eIF6在HCV相关HCC中上调。
- eIF2α、p-eIF4B、eIF5和多种eIF3亚基在慢性HBV相关HCC中显著升高。
- 无病毒背景HCC中eIF亚基p-2α、3C、3I、4E和4G显著升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. The initiation of protein translation is an important rate-limiting step in eukaryotes and is crucial in many viral infections. Eukaryotic translation initiation factors (eIFs) are involved in the initiation step of protein translation and are linked to the phosphatidylinositol-3-kinases PI3K/AKT/mTOR pathway. Therefore we aimed to investigate a potential role of eIFs in HCC. We herein report on the immunohistochemical expression of the various eIF subunits in 235 cases of virus-related human HCC. Additionally, we used immunoblot analysis to investigate the expression of virus-related HCC and non-virus-related HCC in comparison to controls. Mammalian target of rapamycin (or mechanistic target of rapamycin as it is known now (mTOR) and activated mTOR were significantly increased in chronic hepatitis C (HCV)-associated HCC, in HCC without a viral background, in alcoholic liver disease and Wilson disease. pPTEN, phosphatase and tensin homologue (PTEN) and pAKT showed a significant increase in HBV- and HCV-associated HCC, chronic hepatitis B, HCC without a viral background, alcoholic steatohepatitis (ASH) and Wilson disease. Phosphorylated (p)-eIF2α, eIF2α, eiF3B, eIF3D, eIF3J, p-eIF4B, eIF4G and eIF6 were upregulated in HCV-associated HCC. eIF2α, p-eIF4B, eIF5 and various eIF3 subunits were significantly increased in chronic hepatitis B (HBV)-associated HCC. HCC without viral background displayed a significant increase for the eIF subunits p-2α, 3C, 3I, 4E and 4G. We noticed engraved differences in the expression pattern between chronic hepatitis B and C, HBV- and HCV-associated HCC and non-virus-related HCC.
引用
- Golob-Schwarzl N, Krassnig S, Toeglhofer AM, et al. New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors. Eur J Cancer. 2017. PMID: 28715695. doi:10.1016/j.ejca.2017.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。